BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$85.60+0.56 (+0.66%)
Close on Nov 13, 2026Market cap $21.50BP/E –Yield –
BioNTech EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -4.70 EUR. The highest annual figure on record is 39.63 EUR in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -4.70 EUR | – |
| FY2024 | Dec 31, 2024 | -2.77 EUR | -172.3% |
| FY2023 | Dec 31, 2023 | 3.83 EUR | -89.9% |
| FY2022 | Dec 31, 2022 | 37.77 EUR | -4.7% |
| FY2021 | Dec 31, 2021 | 39.63 EUR | +65950.0% |
| FY2020 | Dec 31, 2020 | 0.06 EUR | – |
| FY2019 | Dec 31, 2019 | -0.85 EUR | – |
| FY2018 | Dec 31, 2018 | -0.25 EUR | – |
| FY2017 | Dec 31, 2017 | -0.51 EUR | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?